Pryce, Gareth
109  results:
Search for persons X
?
1

The impact of sphingosine-1-phosphate receptor modulators o..:

Baker, David ; Forte, Eugenia ; Pryce, Gareth...
Multiple Sclerosis and Related Disorders.  69 (2023)  - p. 104425 , 2023
 
?
4

Antigen-specific tolerization in human autoimmunity: Inhibi..:

Marta, Monica ; Baker, David ; Creeke, Paul...
Multiple Sclerosis and Related Disorders.  56 (2021)  - p. 103284 , 2021
 
?
5

The ocrelizumab phase II extension trial suggests the poten..:

Baker, David ; Pryce, Gareth ; James, Louisa K...
Multiple Sclerosis and Related Disorders.  44 (2020)  - p. 102279 , 2020
 
?
8

Potential mechanisms of action related to the efficacy and ..:

Baker, David ; Pryce, Gareth ; Herrod, Samuel S..
Multiple Sclerosis and Related Disorders.  30 (2019)  - p. 176-186 , 2019
 
?
9

Oligoclonal bands in multiple sclerosis; Functional signifi..:

Pryce, Gareth ; Baker, David
Multiple Sclerosis and Related Disorders.  25 (2018)  - p. 131-137 , 2018
 
?
14

Depletion of CD20 B cells fails to inhibit relapsing mouse ..:

Sefia, Eseberuo ; Pryce, Gareth ; Meier, Ute-Christiane..
Multiple Sclerosis and Related Disorders.  14 (2017)  - p. 46-50 , 2017
 
?
15

Antidote to cannabinoid intoxication: the CB1 receptor inve..:

Pryce, Gareth ; Baker, David
British Journal of Pharmacology.  174 (2017)  21 - p. 3790-3794 , 2017
 
1-15